GH
Guardant Health Inc
NASDAQ: GH · HEALTHCARE · DIAGNOSTICS & RESEARCH
$83.41
+0.39% today
Updated 2026-04-29
Market cap
$11.06B
P/E ratio
—
P/S ratio
11.26x
EPS (TTM)
$-3.32
Dividend yield
—
52W range
$36 – $121
Volume
2.0M
Guardant Health Inc (GH) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $25.25M | $49.84M | $90.64M | $214.38M | $286.73M | $373.65M | $449.54M | $563.95M | $739.02M | $982.02M |
| Revenue growth (YoY) | — | +97.4% | +81.9% | +136.5% | +33.8% | +30.3% | +20.3% | +25.5% | +31.0% | +32.9% |
| Cost of revenue | $22.12M | $31.62M | $43.21M | $70.72M | $92.53M | $122.91M | $156.32M | $227.05M | $289.80M | $349.01M |
| Gross profit | $3.13M | $18.22M | $47.43M | $143.66M | $194.19M | $250.74M | $293.21M | $336.90M | $449.22M | $633.01M |
| Gross margin | 12.4% | 36.6% | 52.3% | 67.0% | 67.7% | 67.1% | 65.2% | 59.7% | 60.8% | 64.5% |
| R&D | $10.86M | $25.56M | $50.71M | $86.29M | $149.86M | $263.22M | $373.81M | $367.19M | $347.75M | $364.19M |
| SG&A | $9.92M | $36.78M | $36.19M | $61.40M | $192.77M | $206.64M | $163.96M | $155.80M | $180.12M | $211.41M |
| Operating income | $-43.85M | $-76.61M | $-92.94M | $-82.37M | $-254.95M | $-411.00M | $-544.38M | $-564.73M | $-443.59M | $-436.30M |
| Operating margin | -173.7% | -153.7% | -102.5% | -38.4% | -88.9% | -110.0% | -121.1% | -100.1% | -60.0% | -44.4% |
| EBITDA | $-39.42M | $-75.31M | $-75.84M | $-54.93M | $-225.07M | $-359.62M | $-614.91M | $-433.31M | $-390.12M | $-373.91M |
| EBITDA margin | -156.1% | -151.1% | -83.7% | -25.6% | -78.5% | -96.2% | -136.8% | -76.8% | -52.8% | -38.1% |
| EBIT | $-43.12M | $-80.51M | $-82.97M | $-68.54M | $-241.14M | $-381.89M | $-650.87M | $-476.19M | $-432.51M | $-413.64M |
| Interest expense | $3.02M | $2.70M | $1.25M | $1.18M | $4.77M | $2.58M | $2.58M | $2.58M | $2.58M | $3.90M |
| Income tax | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-46.14M | $-83.22M | $-85.06M | $-75.65M | $-253.78M | $-405.67M | $-654.59M | $-479.45M | $-436.37M | $-416.28M |
| Net income growth (YoY) | — | -80.4% | -2.2% | +11.1% | -235.5% | -59.8% | -61.4% | +26.8% | +9.0% | +4.6% |
| Profit margin | -182.7% | -167.0% | -93.8% | -35.3% | -88.5% | -108.6% | -145.6% | -85.0% | -59.0% | -42.4% |